Tradestie Institutional Equity Comparison Engine
DCTH vs BMRA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DCTH Overall Edge
DCTH Captures Institutional Edge (4โ0 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DCTH trades at N/M Forward P/E with 5.2% operating margin (+70.7% YoY revenue) versus BMRA at N/M Forward P/E and -125.2% operating margin (-8.3% YoY). In options structure, DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro) against BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
DCTH
DCTH N/M vs BMRA N/M Fwd P/E
Growth & Margin Winner
DCTH
Op Margin 5.2% vs -125.2% ยท YoY +70.7% vs -8.3%
Momentum & Technical Winner
DCTH
1Y +130.6% vs -46.9% ยท 52W Pos 82% vs 4%
Options & Structure Winner
DCTH
BREAKOUT (43rd %ile IV) vs UNCLASSIFIED (N/A IV)
DCTH
NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.85
-3.41% 1D
Market Cap
$743.8M
1M Return
+40.98%
1Y Return
+130.55%
Forward P/E
N/M
Unified AI Score
35.9 / 100
SELL
Tech 50.0
Fund 38.0
Flow 60.0
Mom 54.0
BMRA
NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.33
-2.32% 1D
Market Cap
$6.0M
1M Return
-28.19%
1Y Return
-46.86%
Forward P/E
N/M
Unified AI Score
44.5 / 100
HOLD
Tech 40.0
Fund 47.0
Flow 50.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DCTH +130.55%
BMRA -46.86%
Spread: +177.41 pp (DCTH Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | DCTH Revenue | BMRA Revenue | DCTH Op. Margin | BMRA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | N/A | $10M | N/A | -46.4% | BMRA |
| FY2020 | N/A | $10M | N/A | -41.0% | BMRA |
| FY2021 | $0M | $10M | -690.0% | -104.2% | BMRA |
| FY2022 | $0M | $20M | -1245.1% | -24.0% | BMRA |
| FY2023 | $0M | $10M | -1849.0% | -135.3% | BMRA |
| FY2024 | $40M | $10M | -33.4% | -117.6% | DCTH |
| FY2025 | $90M | $10M | 0.8% | -96.7% | DCTH |
| FY2026 | N/A | $0M | N/A | -119.5% | BMRA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DCTH | BMRA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $743.8M | $6.0M | Larger Scale | DCTH |
| Trailing P/E Ratio Valuation | 133.6x | N/M | Lower Multiple | DCTH |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +70.7% | -8.3% | Higher Growth | DCTH |
| Operating Margin (TTM) Profitability | 5.2% | -125.2% | Higher Margin | DCTH |
| Net Profit Margin Profitability | 6.0% | -115.5% | Higher Margin | DCTH |
| Return on Equity (ROE) Capital Efficiency | 5.4% | -113.8% | Higher ROE | DCTH |
| 52-Week Range Position Momentum | 82% ($8โ$23) | 4% ($1โ$3) | Stronger Trend | DCTH |
| Beta / 30D Volatility Risk Regime | 1.65ฮฒ ยท 132% Vol | 0.67ฮฒ ยท 62% Vol | Lower Realized Risk | BMRA |
| Unified Institutional Score Composite Signal | 35.9 / 100 (SELL) | 44.5 / 100 (HOLD) | Higher Composite | BMRA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DCTH vs BMRA Buy Guide
DCTH
BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
43rd %ile
IV Regime
Balanced (25thโ60th %ile)
BMRA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DCTH nor BMRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.